| Publications: |
| Synthesis: |
|---|
| Maublant JC, Moins N, Gachon P. Uptake and release of two new Tc-99m labeled myocardial blood flow imaging agents in cultured cardiac cells. Eur J Nucl Med. 1989;15(4):180-2. Seldin DW, Johnson LL, Blood DK, Muschel MJ, Smith KF, Wall RM, Cannon PJ. Myocardial perfusion imaging with technetium-99m SQ30217: comparison with thallium-201 and coronary anatomy. J Nucl Med. 1989 Mar;30(3):312-9. |
| In vitro analysis: |
|---|
| Maublant JC, Moins N, Gachon P. Uptake and release of two new Tc-99m labeled myocardial blood flow imaging agents in cultured cardiac cells. Eur J Nucl Med. 1989;15(4):180-2. Maublant JC, Zhang Z, Rapp M, Ollier M, Michelot J, Veyre A. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med. 1993 Nov;34(11):1949-52. |
| Animal Studies: |
|---|
| Smith AM, Gullberg GT, Christian PE, Datz FL. Kinetic modeling of teboroxime using dynamic SPECT imaging of a canine model. J Nucl Med. 1994 Mar;35(3):484-95.Heller LI, Villegas BJ, Weiner BH, McSherry BA, Dahlberg ST, Leppo JA. Use of sequential teboroxime imaging for the detection of coronary artery occlusion and reperfusion in ischemic and infarcted myocardium. Am Heart J. 1994 Apr;127(4 Pt 1):779-85. Johnson G 3rd, Glover DK, Hebert CB, Okada RD. Myocardial technetium 99m-labeled teboroxime clearance derived from canine scans differentiates severity of stenosis after dipyridamole. J Nucl Cardiol. 1994 Jul-Aug;1(4):338-50. Okada RD, Glover DK, Moffett JD, Beju D, Johnson G 3rd. Kinetics of technetium-99m-teboroxime in reperfused nonviable myocardium.J Nucl Med. 1997 Feb;38(2):274-9. |
| Clinical Studies: |
|---|
| Abraham SA, Mirecki FN, Levine D, Nunn AD, Strauss HW, Gewirtz H. Myocardial technetium-99m-teboroxime activity in acute coronary artery occlusion and reperfusion: relation to myocardial blood flow and viability. J Nucl Med. 1995 Jun;36(6):1062-8. Johnson LL. Myocardial perfusion imaging with technetium-99m-teboroxime. J Nucl Med. 1994 Apr;35(4):689-92. Henzlova MJ, Machac J. Clinical utility of technetium-99m-teboroxime myocardial washout imaging. J Nucl Med. 1994 Apr;35(4):575-9. Yamagami H, Ishida Y, Morozumi T, Kozuka T, Nishimura T. Detection of coronary artery disease by dynamic planar and single photon emission tomographic imaging with technetium-99m teboroxime. Eur J Nucl Med. 1994 Jan;21(1):27-36. Chua T, Kiat H, Germano G, Palmas W, Takemoto K, Friedman J, Berman DS. Technetium-99m teboroxime regional myocardial washout in subjects with and without coronary artery disease. Am J Cardiol. 1993 Sep 15;72(9):728-34. Bisi G, Sciagra R, Santoro GM, Zerauschek F, Fazzini PF. Evaluatio... |
|
|---|